Healthcare Equipment and Supplies
Company Overview of Vascular Pathways, Inc.
Vascular Pathways, Inc., a medical device company, focuses on the innovation and optimization of peripheral vascular access devices. It offers AccuCath Intravenous Catheter to sample blood, monitor blood pressure, or administer fluids intravenously. The company was incorporated in 2002 and is based in Naples, Florida. As of July 1, 2015, Vascular Pathways, Inc. operates as a subsidiary of CR Bard Inc.
1847 Trade Center Way
Naples, FL 34109
Founded in 2002
Key Executives for Vascular Pathways, Inc.
Chief Executive Officer and President
Vice President of Clinical Affairs
Vice President of Manufacturing
Vice President of Regulatory Affairs and Quality Assurance
Compensation as of Fiscal Year 2015.
Vascular Pathways, Inc. Key Developments
Vascular Pathways Enters into Contract with Novation for AccuCath Line of Catheters
May 6 15
Vascular Pathways reported a new agreement with Novation for their range of AccuCath Catheters. Vascular Pathways announced that through this new agreement, members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista will have access at exclusive member rates to its proprietary line of coiled-tip wire guided catheters designed to increase first attempt success, reduce complication rates, extend dwell times, increase patient satisfaction, and lower overall costs to the provider.
Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015
Dec 10 14
Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015 . Venue: Diplomat Resort & Spa, Hollywood, Florida, United States.
Vascular Pathways, Inc. Names Rudy Mazzocchi Executive Chairman of Board of Directors
Nov 19 14
Vascular Pathways, Inc. announced the company has appointed Rudy Mazzocchi as Executive Chairman of their Board of Directors. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy currently serves as CEO of ELENZA (an Implantable Electro-active Intraocular Lens technology) and previously served as the Interim-CEO of NovaVision Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|